<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McLouth LE</submitter><funding>NIA NIH HHS</funding><pagination>831-836</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10277982</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(6)</volume><pubmed_abstract>&lt;b>&lt;i>Background and Objectives:&lt;/i>&lt;/b> This study describes patients' prognostic awareness and palliative care use in the setting of immunotherapy for metastatic non-small cell lung cancer (mNSCLC). &lt;b>&lt;i>Design:&lt;/i>&lt;/b> We surveyed 60 mNSCLC patients receiving immunotherapy at a large academic medical center; conducted follow-up interviews with 12 survey participants; and abstracted palliative care use, advance directive completion, and death within a year of survey completion from the medical record. &lt;b&gt;&lt;i>Results:&lt;/i>&lt;/b> Forty seven percent of patients surveyed thought they would be cured; 83% were not interested in palliative care. Interviews suggested oncologists emphasized therapeutic options when discussing prognosis and that commonly used descriptions of palliative care may exac</pubmed_abstract><journal>Journal of palliative medicine</journal><pubmed_title>Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer.</pubmed_title><pmcid>PMC10277982</pmcid><funding_grant_id>K23 AG070234</funding_grant_id><pubmed_authors>Petty WJ</pubmed_authors><pubmed_authors>Golden SL</pubmed_authors><pubmed_authors>Lycan TW</pubmed_authors><pubmed_authors>Gabbard J</pubmed_authors><pubmed_authors>Levine BJ</pubmed_authors><pubmed_authors>McLouth LE</pubmed_authors><pubmed_authors>Weaver KE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer.</name><description>&lt;b>&lt;i>Background and Objectives:&lt;/i>&lt;/b> This study describes patients' prognostic awareness and palliative care use in the setting of immunotherapy for metastatic non-small cell lung cancer (mNSCLC). &lt;b>&lt;i>Design:&lt;/i>&lt;/b> We surveyed 60 mNSCLC patients receiving immunotherapy at a large academic medical center; conducted follow-up interviews with 12 survey participants; and abstracted palliative care use, advance directive completion, and death within a year of survey completion from the medical record. &lt;b&gt;&lt;i>Results:&lt;/i>&lt;/b> Forty seven percent of patients surveyed thought they would be cured; 83% were not interested in palliative care. Interviews suggested oncologists emphasized therapeutic options when discussing prognosis and that commonly used descriptions of palliative care may exac</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2026-06-03T04:31:56.618Z</modification><creation>2026-04-24T03:09:52.294Z</creation></dates><accession>S-EPMC10277982</accession><cross_references><pubmed>36912809</pubmed><doi>10.1089/jpm.2022.0352</doi></cross_references></HashMap>